Relationship Between a Vitamin D Genetic Risk Score and Autoantibodies Among First-Degree Relatives of Probands With Rheumatoid Arthritis and Systemic Lupus Erythematosus.
autoantibody negative (aAb-)
autoantibody positive (aAb+)
genetic risk score (GRS)
rheumatoid arthritis (RA)
systemic lupus erythematosus (SLE)
vitamin D
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2022
2022
Historique:
received:
22
02
2022
accepted:
09
05
2022
entrez:
20
6
2022
pubmed:
21
6
2022
medline:
22
6
2022
Statut:
epublish
Résumé
Higher 25-hydroxyvitamin D (25(OH)D) levels have been associated with reduced risk for autoimmune diseases and are influenced by vitamin D metabolism genes. We estimated genetically-determined vitamin D levels by calculating a genetic risk score (GRS) and investigated whether the vitamin D GRS was associated with the presence of autoantibodies related to rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) in those at increased risk for developing RA and SLE, respectively. In this cross-sectional study, we selected autoantibody positive (aAb+) and autoantibody negative (aAb-) individuals from the Studies of the Etiologies of Rheumatoid Arthritis (SERA), a cohort study of first-degree relatives (FDRs) of individuals with RA (189 RA aAb+, 181 RA aAb-), and the Lupus Family Registry and Repository (LFRR), a cohort study of FDRs of individuals with SLE (157 SLE aAb+, 185 SLE aAb-). Five SNPs known to be associated with serum 25(OH)D levels were analyzed individually as well as in a GRS: rs4588 ( Both cohorts had similar demographic characteristics, with significantly older and a higher proportion of males in the aAb+ FDRs. The vitamin D GRS was inversely associated with RA aAb+ (OR = 0.85, 95% CI = 0.74-0.99), suggesting a possible protective factor for RA aAb positivity in FDRs of RA probands. The vitamin D GRS was not associated with SLE aAb+ in the LFRR (OR = 1.09, 95% CI = 0.94-1.27). The Genes associated with vitamin D levels may play a protective role in the development of RA aAbs in FDRs of RA probands, perhaps through affecting lifelong vitamin D status. The GRS and the
Identifiants
pubmed: 35720397
doi: 10.3389/fimmu.2022.881332
pmc: PMC9205604
doi:
Substances chimiques
Autoantibodies
0
Vitamins
0
Vitamin D
1406-16-2
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
881332Subventions
Organisme : NIGMS NIH HHS
ID : U54 GM104938
Pays : United States
Organisme : NIAMS NIH HHS
ID : K23 AR051461
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI144292
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI101981
Pays : United States
Organisme : NIAMS NIH HHS
ID : P30 AR073750
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI101934
Pays : United States
Organisme : NIAMS NIH HHS
ID : P30 AR079369
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR051394
Pays : United States
Organisme : NIAMS NIH HHS
ID : T32 AR007534
Pays : United States
Organisme : NIAMS NIH HHS
ID : P30 AR053483
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI082714
Pays : United States
Organisme : NIGMS NIH HHS
ID : P30 GM103510
Pays : United States
Informations de copyright
Copyright © 2022 Vanderlinden, Bemis, Seifert, Guthridge, Young, Demoruelle, Feser, DeJager, Macwana, Mikuls, O’Dell, Weisman, Buckner, Keating, Gaffney, Kelly, Langefeld, Deane, James, Holers and Norris.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Braz J Med Biol Res. 2007 Dec;40(12):1653-9
pubmed: 17713647
Nutrients. 2019 Mar 21;11(3):
pubmed: 30901909
Nutrients. 2013 Jul 05;5(7):2502-21
pubmed: 23857223
Immunology. 2012 Apr;135(4):344-54
pubmed: 22182481
Nat Med. 2015 Jul;21(7):730-8
pubmed: 26121193
Ann Rheum Dis. 2008 Jun;67(6):801-7
pubmed: 17974596
J Rheumatol. 1987 Oct;14(5):913-21
pubmed: 3430520
Arthritis Rheum. 1988 Mar;31(3):315-24
pubmed: 3358796
Nat Rev Rheumatol. 2017 Jan;13(1):13-24
pubmed: 27811914
Ann N Y Acad Sci. 2014 May;1317:92-8
pubmed: 24814938
Rheumatology (Oxford). 2011 Jan;50(1):47-59
pubmed: 20864496
Am J Hum Genet. 2020 Mar 5;106(3):327-337
pubmed: 32059762
Am J Clin Nutr. 2010 Dec;92(6):1393-8
pubmed: 20943799
J Steroid Biochem Mol Biol. 2020 Feb;196:105516
pubmed: 31678109
Nat Genet. 2012 Mar 25;44(5):483-9
pubmed: 22446960
Curr Rheumatol Rep. 2014 May;16(5):419
pubmed: 24643396
Autoimmun Rev. 2019 Sep;18(9):102350
pubmed: 31323357
Arthritis Rheum. 2009 Dec 15;61(12):1735-42
pubmed: 19950324
Biomed Res Int. 2019 May 7;2019:3494937
pubmed: 31205940
J Rheumatol. 2009 May;36(5):943-6
pubmed: 19286844
BMC Med. 2013 Mar 18;11:73
pubmed: 23497011
N Engl J Med. 2007 Jul 19;357(3):266-81
pubmed: 17634462
Best Pract Res Clin Rheumatol. 2017 Feb;31(1):3-18
pubmed: 29221595
Am J Clin Nutr. 2011 Mar;93(3):667-8; author reply 668
pubmed: 21248189
Clin Rheumatol. 2018 Sep;37(9):2415-2421
pubmed: 29799605
J Pharmacol Pharmacother. 2012 Apr;3(2):118-26
pubmed: 22629085
Ann Rheum Dis. 2017 Jan;76(1):153-158
pubmed: 27283331
N Engl J Med. 2003 Oct 16;349(16):1526-33
pubmed: 14561795
Arthritis Rheum. 1982 Nov;25(11):1271-7
pubmed: 7138600
Best Pract Res Clin Rheumatol. 2017 Jun;31(3):306-320
pubmed: 29224673
Nat Commun. 2018 Jan 17;9(1):260
pubmed: 29343764
J Investig Med. 2011 Aug;59(6):881-6
pubmed: 21527855
BMJ. 2022 Jan 26;376:e066452
pubmed: 35082139
Arthritis Care Res (Hoboken). 2014 Oct;66(10):1438-46
pubmed: 25103278
Science. 2003 Apr 11;300(5617):337-9
pubmed: 12690201
EBioMedicine. 2019 Apr;42:76-85
pubmed: 30952617
Arthritis Rheum. 2012 Nov;64(11):3677-86
pubmed: 23112091
Am J Med. 1975 Oct;59(4):533-52
pubmed: 1101680